Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 7R01CA212608-02
Probing RAS-mediated signaling mechanisms with monobody inhibitors
National Institutes of Health
Grant: 1R21AI158997-01
Accurate prediction of neutralization capacity from deep mining of SARS-CoV-2 serology
National Institutes of Health
Grant: 1R01CA194864-01A1
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins
National Institutes of Health
Grant: 5P30CA016087-32
Experimental Pathology
Fields of Study
Sustainable Development Goals
Additional file 1 of Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Additional file 1 of Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis